Sitemap

• Home
  • Sign up for our Newsletter
• About Us
  • Introducing Skyline
  • Vision & History
  • Leadership
    • Executives Management
      • Kurt Schmidt
      • Bob Löwenberg
      • Leonie de Best
    • Scientific advisory board
      • Ruud Delwel
      • Pieter Sonneveld
      • Peter van der Spek
      • Ivo Touw
      • Peter Valk
    • Supervisory board
      • Jan Egberts
      • John de Koning
      • Christian Schneider
      • Tom Schwarz
      • Henk Viëtor
  • Careers
    • Sr. QA/RA Officer
• Knowledge Center
• Products & Services
  • AMLprofiler
    • Seven assays in one
    • AMLprofiler publications
    • AMLprofiler Assay: Three days to diagnosis
    • AMLprofiler + Leukostrat FLT3
      • 3 steps
    • Technical data
  • MMprofiler
    • Assay Content
    • Scientific Background References for the MMprofiler
• Partnering
  • Pharmaceutical companies
  • Inventors of new biomarkers or signatures
• News and Events
  • News
    • Skyline's method for detecting CEBPA dm accepted for publication
    • Skyline to participate in the STW project "Genes in Space"
    • Skyline's method for detecting NPM1 mutations accepted for publication
    • New CEO appointed at Skyline Diagnostics
    • Skyline Update ASH 2012
  • Events
    • Skyline at AMP 2012, Long Beach, California
    • Skyline at the ASH 2012, Atlanta, Georgia
    • Skyline Diagnostics at the EHA 2012 Exhibition
    • BIO-Europe Spring 2012
    • Bridging the Gap 2012
    • CTMM Annual Meeting 2011
    • Skyline attends the ESH-EHA Workshop
    • EHA 2011 Exhibition
    • EHA 2011
    • Launch-Event
• Contact Us
  • Inquiries
  • Sign up for our Newsletter
  • General Terms & Conditions
• Content